Oracle (ORCL)
(Delayed Data from NYSE)
$169.59 USD
-0.43 (-0.25%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $169.33 -0.26 (-0.15%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$169.59 USD
-0.43 (-0.25%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $169.33 -0.26 (-0.15%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Zacks News
Oracle (ORCL) Enables Royal Flying Doctor Service's Record
by Zacks Equity Research
Oracle (ORCL) enables the Royal Flying Doctor Service to unveil a fresh digital health record solution, leveraging the capabilities of Oracle Autonomous Database.
Oracle (ORCL) Helps MosaicML to Accelerate AI Model Training
by Zacks Equity Research
Oracle (ORCL) announces that it has been selected by MosaicML as the preferred cloud infrastructure partner to accelerate AI model training.
2 Stocks With Bullish "Shakeout" Patterns
by Andrew Rocco
During a shakeout, weaker and more speculative investors tend to panic and sell their holdings. However, Strategist Andrew Rocco explains why this process can clear out the market of these unstable participants, leaving behind a more resilient investor base.
Oracle (ORCL) Collaborates With White House CancerX Project
by Zacks Equity Research
Oracle (ORCL) partners with the White House CancerX Initiative as a founding member to contribute to the battle against cancer.
Oracle (ORCL) Stock Moves -0.04%: What You Should Know
by Zacks Equity Research
Oracle (ORCL) closed at $116.54 in the latest trading session, marking a -0.04% move from the prior day.
Here is What to Know Beyond Why Oracle Corporation (ORCL) is a Trending Stock
by Zacks Equity Research
Oracle (ORCL) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Should iShares MSCI USA Min Vol Factor ETF (USMV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for USMV
Oracle (ORCL) Achieves Authorization for Top-Secret Cloud Data
by Zacks Equity Research
Oracle (ORCL) Cloud Infrastructure receives authorization to host classified TS/SCI missions by the U.S. Intelligence Community.
Zacks Investment Ideas feature highlights: Microsoft, Netflix, Nvidia, Ionq and Oracle
by Zacks Equity Research
Microsoft, Netflix, Nvidia, Ionq and Oracle have been highlighted in this Investment Ideas article.
Oracle (ORCL) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Oracle (ORCL) closed the most recent trading day at $117.29, moving +1.49% from the previous trading session.
AI "Gold Rush": Focus on 3 Stocks Selling the "Picks"
by Andrew Rocco
ChatGPT took the world by storm in late 2022. Moving forward, investors looking to cash in on the AI revolution have two choices: bet on a company they think can win the AI race, or bet on the companies necessary to run AI.
The Zacks Analyst Blog Oracle, Chevron, Linde, The Walt Disney, and Airbnb
by Zacks Equity Research
Oracle, Chevron, Linde, The Walt Disney, and Airbnb are part of the Zacks top Analyst Blog.
Top Analyst Reports for Oracle, Chevron & Linde
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Oracle Corporation (ORCL), Chevron Corporation (CVX) and Linde plc (LIN).
Is the AI Party Over? 5 Drivers for the Next Surge
by Andrew Rocco
AI is the game-changing innovation of the current bull market cycle. However, short-term price action often forms false opinions for investors. Stock Strategist Andrew Rocco explains where we are in the cycle.
Should You Invest in the First Trust Cloud Computing ETF (SKYY)?
by Zacks Equity Research
Sector ETF report for SKYY
Oracle (ORCL) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Oracle (ORCL) closed at $113.10 in the latest trading session, marking a -1.85% move from the prior day.
Beat the Market Like Zacks: NVIDIA, Oracle, The Home Depot in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Take the Zacks Approach to Beat the Market: NVIDIA, Oracle, Celsius in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Is WisdomTree U.S. Multifactor ETF (USMF) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for USMF
Oracle (ORCL) Health's EHR Joins Universal Health Services
by Zacks Equity Research
Oracle (ORCL) Health's EHR is set to be incorporated into Universal Health Services' behavioral health facilities.
Oracle (ORCL) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Oracle (ORCL) closed at $118.69 in the latest trading session, marking a -1.72% move from the prior day.
Is Trending Stock Oracle Corporation (ORCL) a Buy Now?
by Zacks Equity Research
Oracle (ORCL) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Oracle (ORCL) Fusion Cloud Partners With Texas Children's Hospital
by Zacks Equity Research
Oracle (ORCL) announces that its Fusion Cloud Applications Suite has been chosen as the standardized solution for the largest children's hospital in the United States.
Oracle (ORCL) Down 1.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Oracle (ORCL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Beat the Market Like Zacks: Shopify, Medtronic, Oracle in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.